Zydus Lifesciences Ltd

Zydus Lifesciences Ltd | Sector: Pharmaceuticals | ISIN: INE010B01027

₹ 483.95 (0.68%)

27 Mar, 2023, 9:31:15 AM

Expiry Date:

ZYDUSLIFE - 29-03-2023

CALLS						PUTS
Total OI	Chg in Ol	Chg % Ol	LTP	Chg %	Strike Price	Chg %	LTP	Chg % OI	Chg in Ol	Total OI
-	-	-	-	0.00	380.00	0.00	0.25	0.0	0	5400
-	-	-	-	0.00	390.00	0.00	0.1	0.0	0	27000
9000	0	0.00	79.95	0.00	400.00	0.00	0.1	0.0	0	48600
-	-	-	-	0.00	405.00	0.00	0.15	0.0	0	30600
-	-	-	-	0.00	420.00	0.00	0.1	0.0	0	37800
-	-	-	-	0.00	425.00	0.00	0.5	0.0	0	3600
-	-	-	-	0.00	430.00	0.00	0.35	0.0	0	18000
-	-	-	-	0.00	435.00	0.00	1.7	0.0	0	0
1800	0	0.00	37.3	0.00	440.00	0.00	0.05	0.0	0	55800
0	0	0.00	34.3	0.00	445.00	0.00	1.35	0.0	0	0

Open
₹ 475.25

Prev. Close
₹ 480.70

Turnover(lac)
₹ 640.20

Day's High
₹ 485.00

Day's Low
₹ 475.05

52 Wk High
₹ 488.30

52 Wk Low
₹ 319.00

Book Value
₹ 141.06

Face Value
₹ 1.00

Mkt. Cap (Cr.)
₹ 49,051.41

P/E
37.83

EPS
12.70

Div. Yield
0.53

Corporate Actions

23 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

23 Jan , 2023

12:00 AM

Results

05 Dec , 2022

12:00 AM

EGM

29 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

31 Oct , 2022

12:00 AM

Results

31 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

03 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

20 May , 2022

12:00 AM

AGM

Announcement date: 20 May , 2022

03 Aug , 2022

12:00 AM

Results

20 May , 2022

12:00 AM

Dividend

Dividend amount: 2.5
Announcement date: 20 May , 2022

13 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

Zydus Lifesciences Ltd News and Update

Image not found

Adani Power sells Support Properties Private Ltd to AdaniConnex

24 March, 2023 |
4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

Govt to sell up to 3.5% stake in HAL

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	980.00	89.99	2,33,407.31	486.73	1.03	4,549.90	108.48
Divis Laboratories Ltd	2,828.85	31.40	74,497.12	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,525.00	31.49	74,309.82	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	881.35	25.58	70,787.11	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,526.25	48.99	51,379.40	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Zydus Lifesciences Ltd

Pankaj R Patel
Chairman (Non-Executive)

Sharvil P Patel
Managing Director

Mukesh M Patel
Director

Nitin Raojibhai Desai
Independent Director

Dharmishta N Rawal
Independent Director

Apurva S Diwanji
Independent Director

Ganesh N Nayak
Executive Director

Bhadresh K Shah
Independent Director

Dhaval N Soni
Company Secretary

Summary

Summary Info Not Found

Reports by Zydus Lifesciences Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Zydus Lifesciences Ltd
Investor PresentationConference Call TranscriptConference Call Audio